Resilience of Spike-Specific Immunity Induced by COVID-19 Vaccines against SARS-CoV-2 Variants

The outbreak of SARS-CoV-2 leading to the declaration of the COVID-19 global pandemic has led to the urgent development and deployment of several COVID-19 vaccines. Many of these new vaccines, including those based on mRNA and adenoviruses, are aimed to generate neutralizing antibodies against the s...

Descripción completa

Detalles Bibliográficos
Autores principales: Ballesteros-Sanabria, Laura, Pelaez-Prestel, Hector F., Ras-Carmona, Alvaro, Reche, Pedro A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138591/
https://www.ncbi.nlm.nih.gov/pubmed/35625733
http://dx.doi.org/10.3390/biomedicines10050996

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138591/
https://www.ncbi.nlm.nih.gov/pubmed/35625733
http://dx.doi.org/10.3390/biomedicines10050996

Ejemplares similares